Completed PHASE3 INTERVENTIONAL 2-arm NCT01022463

Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm (IVA-MS)

Effect of Ivabradine vs Atenolol on Heart Rate and Effort Tolerance in Patients With Mild to Moderate Mitral Stenosis and Normal Sinus Rhythm

Sponsor: Govind Ballabh Pant Hospital

Conditions Mitral Stenosis

Interventions Atenolol Ivabradine

Updated 5 times since 2017 Last updated: Jul 6, 2011 Started: Nov 30, 2009 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Mitral Stenosis and is currently completed. Govind Ballabh Pant Hospital leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Govind Ballabh Pant Hospital

Data source: Govind Ballabh Pant Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Delhi, India